Mercury Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.20 Cr
as on 12-12-2024
- Company Age 42 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.81 Cr
as on 12-12-2024
- Satisfied Charges ₹ 33.61 Cr
as on 12-12-2024
- Revenue -15.46%
(FY 2022)
- Profit -30.94%
(FY 2022)
- Ebitda -25.82%
(FY 2022)
- Net Worth 9.34%
(FY 2022)
- Total Assets -3.28%
(FY 2022)
About Mercury Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 538964.
The Corporate was formerly known as Mercury Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹15.81 Cr. The company has closed loans amounting to ₹33.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mercury Laboratories Limited India are Ashish Vasavada as CFO and Krishna Shah as Company Secretary. Dilip Shah, Rajendrakumar Shah, Bharat Mehta, and Three other members serve as directors at the Company.
- CIN/LLPIN
L74239MH1982PLC026341
- Company No.
026341
- Stock Symbol
BSE : 538964
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Feb 1982
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mercury Laboratories Limited offer?
Mercury Laboratories Limited offers a wide range of products and services, including Women Care, Women Care Supplements.
Who are the key members and board of directors at Mercury Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendrakumar Shah  | Managing Director | 16-Feb-1982 | Current |
| Ashish Vasavada | CFO | 21-Oct-2021 | Current |
| Krishna Shah | Company Secretary | 31-Jan-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paresh Mistry | Director | 01-Oct-2017 | Current |
| Bharat Mehta | Director | 14-May-2015 | Current |
Dilip Shah  | Director | 16-Feb-1982 | Current |
| Janki Shah | Director | 05-Feb-2020 | Current |
| Jayantilal Raval | Director | 24-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Mercury Laboratories.
Mercury Laboratories Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.46% decrease. The company also saw a substantial fall in profitability, with a 30.94% decrease in profit. The company's net worth moved up by a moderate rise of 9.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mercury Laboratories?
In 2022, Mercury Laboratories had a promoter holding of 73.66% and a public holding of 26.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Mar 2024 | ₹2.00 M | Open |
Hdfc Bank Limited Creation Date: 25 May 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 27 Sep 2021 | ₹7.06 Cr | Open |
How Many Employees Work at Mercury Laboratories?
Mercury Laboratories has a workforce of 489 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mercury Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercury Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
